{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:44Z","timestamp":1791906464652,"version":"4.3.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"The University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trecan.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:42:48Z","timestamp":1782531768000},"page":"902-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals"],"prefix":"10.1016","volume":"12","author":[{"given":"Lei","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-4438","authenticated-orcid":false,"given":"Vivian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.06.002_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"Mendez-Ferrer","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.06.002_bb0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ccell.2024.02.001","article-title":"Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients","volume":"42","author":"Radtke","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/953982","article-title":"The bone marrow microenvironment as niche retreats for hematopoietic and leukemic stem cells","volume":"2013","author":"Nwajei","year":"2013","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fonc.2018.00288","article-title":"Microenvironment cell contribution to lymphoma immunity","volume":"8","author":"Kumar","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood.2023020999","article-title":"The follicular lymphoma tumor microenvironment at single-cell and spatial resolution","volume":"143","author":"Radtke","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0030","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.trecan.2026.06.002_bb0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41420-025-02505-w","article-title":"Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.trecan.2026.06.002_bb0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.06.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55098-w","article-title":"Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening","volume":"15","author":"Santamaria-Martinez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.06.002_bb0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.stem.2024.01.012","article-title":"A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment","volume":"31","author":"Kastenschmidt","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/cancers14051360","article-title":"The Hodgkin lymphoma immune microenvironment: turning bad news into good","volume":"14","author":"Menendez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.06.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102755","article-title":"Hematopoietic organoids: opportunities and challenges in modeling human hematopoiesis and diseases in vitro","volume":"21","author":"Du","year":"2026","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.trecan.2026.06.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13806","article-title":"Organoids in haematologic research: advances and future directions","volume":"58","author":"Chang","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.trecan.2026.06.002_bb0070","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41592-024-02172-2","article-title":"Generation of complex bone marrow organoids from human induced pluripotent stem cells","volume":"21","author":"Frenz-Wiessner","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2026.06.002_bb0075","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor organoids as a pre-clinical cancer model for drug discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.641980","article-title":"Patient-derived cancer organoids as predictors of treatment response","volume":"11","author":"Verduin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0085","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1182\/bloodadvances.2020003949","article-title":"A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival","volume":"5","author":"Lamaison","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2026.06.002_bb0090","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/2159-8290.CD-22-0199","article-title":"Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies","volume":"13","author":"Khan","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.06.002_bb0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2015.09.007","article-title":"Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells","volume":"73","author":"Tian","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.trecan.2026.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0110","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1038\/s41375-025-02739-8","article-title":"A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia","volume":"39","author":"Kanari","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.06.002_bb0115","article-title":"Developing a 3D B cell lymphoma culture system to model antibody therapy","volume":"11","author":"Foxall","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/OTT.S363994","article-title":"Development and characterization of 3D hybrid spheroids for the investigation of the crosstalk between B-cell non-Hodgkin lymphomas and mesenchymal stromal cells","volume":"15","author":"Du\u015b-Szachniewicz","year":"2022","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.trecan.2026.06.002_bb0125","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41375-023-01885-1","article-title":"A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses","volume":"37","author":"Araujo-Ayala","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.06.002_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007156","article-title":"Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine","volume":"11","author":"Faria","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2026.06.002_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41408-024-01041-7","article-title":"Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target","volume":"14","author":"Dobano-Lopez","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.trecan.2026.06.002_bb0140","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1182\/blood-2019-131192","article-title":"Follicular lymphoma organoids for investigating the tumor microenvironment","volume":"134","author":"Wagar","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0145","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood.2024026919","article-title":"TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma","volume":"146","author":"Wang","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0150","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1182\/blood-2021-152994","article-title":"Establishment of patient-derived organoid culture platform of mantle cell lymphoma","volume":"138","author":"Nie","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0155","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1182\/blood-2022-169622","article-title":"Establishment of a patient-derived organoid culture platform for mantle cell lymphoma drug sensitivity and CAR T cell anti-tumor activity assay","volume":"140","author":"Nie","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0160","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood-2024-208895","article-title":"Evaluating full antitumor activities of monoclonal antibody and innate immune cells in relapsed\/refractory mantle cell lymphoma using ex vivo organoid platform","volume":"144","author":"Nie","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0165","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41375-025-02562-1","article-title":"Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma","volume":"39","author":"Li","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.06.002_bb0170","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/blood.2019004713","article-title":"Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL","volume":"137","author":"Fontan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0175","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1182\/bloodadvances.2020002580","article-title":"Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes","volume":"4","author":"Scholze","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2026.06.002_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11912-020-0885-0","article-title":"Acute myeloid leukaemia in its niche: the bone marrow microenvironment in acute myeloid leukaemia","volume":"22","author":"Ladikou","year":"2020","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.trecan.2026.06.002_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746492","article-title":"Patient-derived bone marrow spheroids reveal leukemia-initiating cells supported by mesenchymal hypoxic niches in pediatric B-ALL","volume":"12","author":"Balandr\u00e1n","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0190","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.3390\/cancers14215252","article-title":"The potential role of 3D in vitro acute myeloid leukemia culture models in understanding drug resistance in leukemia stem cells","volume":"14","author":"Al-Kaabneh","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.06.002_bb0195","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.drudis.2016.04.019","article-title":"Three-dimensional ex vivo co-culture models of the leukaemic bone marrow niche for functional drug testing","volume":"21","author":"Dhami","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.trecan.2026.06.002_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI43605","article-title":"BCR-ABL kinase is dead; long live the CML stem cell","volume":"121","author":"Perl","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2026.06.002_bb0205","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.4237","article-title":"Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids","volume":"14","author":"Seet","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2026.06.002_bb0215","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1182\/bloodadvances.2020001730","article-title":"Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia","volume":"4","author":"Bosticardo","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2026.06.002_bb0220","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/bloodadvances.2023011145","article-title":"A brain organoid\/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL","volume":"8","author":"Gebing","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2026.06.002_bb0225","article-title":"Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro","volume":"5","author":"Barozzi","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.trecan.2026.06.002_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70170","article-title":"A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia","volume":"9","author":"Lenti","year":"2025","journal-title":"Hemasphere"},{"key":"10.1016\/j.trecan.2026.06.002_bb0235","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/s41375-024-02284-w","article-title":"Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs","volume":"38","author":"Hoferkova","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.trecan.2026.06.002_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639572","article-title":"3D bioprinting allows the establishment of long-term 3D culture model for chronic lymphocytic leukemia cells","volume":"12","author":"Sbrana","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41420-023-01426-w","article-title":"A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine","volume":"9","author":"Hermansen","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.trecan.2026.06.002_bb0250","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ccell.2025.06.002","article-title":"Large B cell lymphoma microenvironment archetype profiles","volume":"43","author":"Li","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0255","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41467-017-01029-x","article-title":"EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop","volume":"8","author":"Beguelin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.06.002_bb0260","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/bloodadvances.2025016511","article-title":"YX0798 is a highly potent, selective, and orally effective CDK9 inhibitor for treating aggressive lymphoma","volume":"9","author":"Jiang","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2026.06.002_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112888","article-title":"Patient-derived multiple myeloma 3D models for personalized medicine-are we there yet?","volume":"23","author":"Lourenco","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2026.06.002_bb0270","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2008-02-142430","article-title":"A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma","volume":"112","author":"Kirshner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.06.002_bb0275","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/cancers12082006","article-title":"Ex vivo models simulating the bone marrow environment and predicting response to therapy in multiple myeloma","volume":"12","author":"Papadimitriou","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.06.002_bb0280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13036-025-00570-4","article-title":"Human preclinical multiple myeloma in vitro models for disease modeling and therapy screening","volume":"19","author":"Ybarra","year":"2025","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.trecan.2026.06.002_bb0285","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1538-7445.AM2023-184","article-title":"Multiple myeloma 3D model: a platform for testing drug effects on myeloma in conjunction with the bone marrow niche","volume":"83","author":"Rashad","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.06.002_bb0290","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.clml.2019.09.045","article-title":"High throughput 3D bioprinting of patient-derived multiple myeloma organoid models for niche recapitulation and chemosensitivity assessment","volume":"19","author":"Rodriguez","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.trecan.2026.06.002_bb0295","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.06.002_bb0300","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1158\/0008-5472.CAN-16-2171","article-title":"Activation of NOTCH signaling by tenascin-C promtoes growth of human brain tumor-initiating cells","volume":"77","author":"Sarkar","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.06.002_bb0305","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.06.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103103","article-title":"Protocol for in vitro co-culture assay for rapid expansion of human T cell acute lymphoblastic leukemia","volume":"5","author":"Rivera","year":"2024","journal-title":"STAR Protoc."},{"key":"10.1016\/j.trecan.2026.06.002_bb0315","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.06.002_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","article-title":"Cancer stem cells and niches: challenges in immunotherapy resistance","volume":"24","author":"Pan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.trecan.2026.06.002_bb0325","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.3390\/ijms25126639","article-title":"Leukemic stem cells and hematological malignancies","volume":"25","author":"Choi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2026.06.002_bb0330","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/bloodadvances.2024013361","article-title":"Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment","volume":"9","author":"Ren","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.trecan.2026.06.002_bb0335","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/biom14081003","article-title":"Development of VLA4 and CXCR4 antagonists for the mobilization of hematopoietic stem and progenitor cells","volume":"14","author":"Ruminski","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.trecan.2026.06.002_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1310292","article-title":"Unraveling the enigma of B cells in diffuse large B-cell lymphoma: unveiling cancer stem cell-like B cell subpopulation at single-cell resolution","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/d41573-025-00087-x","article-title":"Is the FDA\u2019s plan to phase out animal toxicity testing realistic?","volume":"24","author":"Mullard","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2026.06.002_bb0350","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/aor.14503","article-title":"FDA Modernization Act 2.0 allows for alternatives to animal testing","volume":"47","author":"Han","year":"2023","journal-title":"Artif. Organs"},{"key":"10.1016\/j.trecan.2026.06.002_bb0355","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175824","article-title":"FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2026.06.002_bb0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0365","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0370","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2026.06.002_bb0375","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41596-020-00474-1","article-title":"Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids","volume":"16","author":"Dekkers","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2026.06.002_bb0380","first-page":"17","article-title":"Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety","volume":"13","author":"Botti","year":"2021","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0385","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1136\/gutjnl-2019-320019","article-title":"Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles","volume":"69","author":"Yan","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2026.06.002_bb0390","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2018.08.017","article-title":"Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids","volume":"436","author":"Liu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2026.06.002_bb0395","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4251\/wjgo.v11.i7.509","article-title":"Utilizing gastric cancer organoids to assess tumor biology and personalize medicine","volume":"11","author":"Lin","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0400","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","article-title":"Organoid models of human liver cancers derived from tumor needle biopsies","volume":"24","author":"Nuciforo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2026.06.002_bb0405","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/jnci\/djz241","article-title":"Genetic factors, adherence to healthy lifestyle behavior, and risk of invasive breast cancer among women in the UK biobank","volume":"112","author":"Arthur","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2026.06.002_bb0410","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0415","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0420","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41563-020-00803-5","article-title":"Recapitulating macro-scale tissue self-organization through organoid bioprinting","volume":"20","author":"Brassard","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.trecan.2026.06.002_bb0425","doi-asserted-by":"crossref","first-page":"364","DOI":"10.18063\/ijb.v7i3.364","article-title":"Developments and opportunities for 3D bioprinted organoids","volume":"7","author":"Ren","year":"2021","journal-title":"Int. J. Bioprinting"},{"key":"10.1016\/j.trecan.2026.06.002_bb0430","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41563-020-00853-9","article-title":"Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation","volume":"20","author":"Lawlor","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.trecan.2026.06.002_bb0435","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-019-0305-x","article-title":"A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids","volume":"2","author":"Phan","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0440","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/mi11020208","article-title":"Immersion bioprinting of tumor organoids in multi-well plates for increasing chemotherapy screening throughput","volume":"11","author":"Maloney","year":"2020","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.trecan.2026.06.002_bb0445","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","article-title":"Patient-derived micro-organospheres enable clinical precision oncology","volume":"29","author":"Ding","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119536","article-title":"Progress in 3D bioprinting technology for tissue\/organ regenerative engineering","volume":"226","author":"Matai","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.trecan.2026.06.002_bb0455","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41698-020-0121-2","article-title":"3D bioprinting for reconstituting the cancer microenvironment","volume":"4","author":"Datta","year":"2020","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0460","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/2159-8290.CD-20-1109","article-title":"A CRISPR\/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and nonessential modes of oncogenic transformation","volume":"11","author":"Lo","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.06.002_bb0465","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","article-title":"Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing","volume":"22","author":"Artegiani","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2026.06.002_bb0470","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41596-021-00506-4","article-title":"Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells","volume":"16","author":"Caeser","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.trecan.2026.06.002_bb0475","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","article-title":"Patient-derived organoids in precision cancer medicine","volume":"5","author":"Tong","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.trecan.2026.06.002_bb0480","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-020-01145-0","article-title":"Modeling human adaptive immune responses with tonsil organoids","volume":"27","author":"Wagar","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2026.06.002_bb0485","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.stem.2025.01.014","article-title":"Systems immunology analysis of human immune organoids identifies host-specific correlates of protection to different influenza vaccines","volume":"32","author":"Wagoner","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.06.002_bb0490","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41563-024-02037-1","article-title":"Human immune organoids to decode B cell response in healthy donors and patients with lymphoma","volume":"24","author":"Zhong","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.trecan.2026.06.002_bb0495","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/dgd.12708","article-title":"Human liver model systems in a dish","volume":"63","author":"Thompson","year":"2021","journal-title":"Develop. Growth Differ."},{"key":"10.1016\/j.trecan.2026.06.002_bb0500","first-page":"525","article-title":"AI-enabled organoids: construction, analysis, and application","volume":"31","author":"Bai","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.trecan.2026.06.002_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.medntd.2023.100276","article-title":"Organoid intelligence: integration of organoid technology and artificial intelligence in the new era of in vitro models","volume":"21","author":"Shi","year":"2024","journal-title":"Med. Novel Technol. Devices"}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:12:38Z","timestamp":1791904358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326001305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2405803326001305"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.06.002","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}